Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 8 | 2025 | 291 | 2.530 |
Why?
|
| Photosensitizing Agents | 3 | 2021 | 35 | 1.430 |
Why?
|
| Drug Delivery Systems | 4 | 2025 | 236 | 1.050 |
Why?
|
| Quercetin | 2 | 2021 | 14 | 0.850 |
Why?
|
| Isoindoles | 2 | 2021 | 5 | 0.840 |
Why?
|
| Zinc Compounds | 2 | 2021 | 4 | 0.840 |
Why?
|
| Zebrafish | 1 | 2024 | 96 | 0.810 |
Why?
|
| Organometallic Compounds | 2 | 2021 | 42 | 0.810 |
Why?
|
| Polymers | 2 | 2019 | 117 | 0.700 |
Why?
|
| Photochemotherapy | 5 | 2021 | 42 | 0.680 |
Why?
|
| Biocompatible Materials | 2 | 2021 | 95 | 0.680 |
Why?
|
| Liposomes | 1 | 2021 | 145 | 0.630 |
Why?
|
| Cell Survival | 5 | 2025 | 419 | 0.620 |
Why?
|
| Theranostic Nanomedicine | 1 | 2019 | 25 | 0.590 |
Why?
|
| Drug Carriers | 3 | 2025 | 119 | 0.570 |
Why?
|
| Hydrogels | 3 | 2025 | 59 | 0.470 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 686 | 0.460 |
Why?
|
| Ear, Inner | 2 | 2025 | 13 | 0.450 |
Why?
|
| Drug Liberation | 2 | 2025 | 29 | 0.410 |
Why?
|
| Delayed-Action Preparations | 2 | 2025 | 44 | 0.400 |
Why?
|
| Lignin | 3 | 2021 | 17 | 0.370 |
Why?
|
| MCF-7 Cells | 3 | 2021 | 34 | 0.360 |
Why?
|
| Lipids | 2 | 2025 | 218 | 0.350 |
Why?
|
| Light | 2 | 2021 | 118 | 0.330 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2021 | 554 | 0.320 |
Why?
|
| Antioxidants | 3 | 2021 | 224 | 0.320 |
Why?
|
| Anti-Infective Agents | 2 | 2020 | 78 | 0.300 |
Why?
|
| Cisplatin | 2 | 2025 | 186 | 0.260 |
Why?
|
| Animals | 6 | 2025 | 10684 | 0.250 |
Why?
|
| Reactive Oxygen Species | 3 | 2025 | 292 | 0.240 |
Why?
|
| Thiosulfates | 1 | 2025 | 7 | 0.240 |
Why?
|
| Poloxamer | 1 | 2025 | 6 | 0.240 |
Why?
|
| Gelatin | 1 | 2025 | 11 | 0.240 |
Why?
|
| Ciprofloxacin | 1 | 2025 | 22 | 0.230 |
Why?
|
| Dexamethasone | 1 | 2025 | 63 | 0.230 |
Why?
|
| Cornea | 1 | 2025 | 72 | 0.230 |
Why?
|
| Sirolimus | 1 | 2025 | 76 | 0.220 |
Why?
|
| Lignans | 1 | 2024 | 10 | 0.220 |
Why?
|
| Wound Healing | 1 | 2025 | 126 | 0.220 |
Why?
|
| Biphenyl Compounds | 1 | 2024 | 22 | 0.220 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2021 | 46 | 0.190 |
Why?
|
| Cell Line | 1 | 2024 | 700 | 0.190 |
Why?
|
| Nanocapsules | 1 | 2021 | 4 | 0.180 |
Why?
|
| Porphyrins | 1 | 2021 | 20 | 0.170 |
Why?
|
| Cell Membrane Permeability | 1 | 2021 | 44 | 0.170 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2021 | 24 | 0.170 |
Why?
|
| Neoplasms | 2 | 2021 | 874 | 0.170 |
Why?
|
| Sunscreening Agents | 1 | 2019 | 5 | 0.160 |
Why?
|
| Zinc Oxide | 1 | 2019 | 3 | 0.160 |
Why?
|
| Mycophenolic Acid | 1 | 2019 | 18 | 0.160 |
Why?
|
| Mice | 3 | 2025 | 4802 | 0.160 |
Why?
|
| Nanocomposites | 1 | 2019 | 14 | 0.160 |
Why?
|
| Fatty Alcohols | 1 | 2019 | 4 | 0.160 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 137 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 2 | 2021 | 536 | 0.150 |
Why?
|
| Humans | 6 | 2025 | 28851 | 0.150 |
Why?
|
| Singlet Oxygen | 1 | 2019 | 5 | 0.150 |
Why?
|
| Transplantation, Heterologous | 1 | 2019 | 60 | 0.150 |
Why?
|
| Rats | 2 | 2019 | 1588 | 0.150 |
Why?
|
| Microscopy, Confocal | 1 | 2019 | 113 | 0.150 |
Why?
|
| Paclitaxel | 1 | 2019 | 200 | 0.140 |
Why?
|
| Polyethylene Glycols | 1 | 2019 | 101 | 0.140 |
Why?
|
| Indoles | 1 | 2019 | 110 | 0.140 |
Why?
|
| Acebutolol | 1 | 2015 | 1 | 0.120 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2015 | 5 | 0.120 |
Why?
|
| Particle Size | 2 | 2025 | 105 | 0.100 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2019 | 36 | 0.080 |
Why?
|
| Molecular Structure | 2 | 2021 | 245 | 0.070 |
Why?
|
| Quantum Theory | 1 | 2021 | 22 | 0.040 |
Why?
|
| Fluorescence | 1 | 2021 | 51 | 0.040 |
Why?
|
| Bacillus megaterium | 1 | 2021 | 1 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2021 | 103 | 0.040 |
Why?
|
| Surface Properties | 1 | 2021 | 134 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 202 | 0.040 |
Why?
|
| Nanoconjugates | 1 | 2020 | 18 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2021 | 149 | 0.040 |
Why?
|
| Lasers | 1 | 2020 | 68 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2020 | 270 | 0.040 |
Why?
|
| A549 Cells | 1 | 2019 | 17 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2019 | 40 | 0.040 |
Why?
|
| Spheroids, Cellular | 1 | 2019 | 53 | 0.040 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2019 | 54 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2019 | 190 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 278 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2019 | 292 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2021 | 338 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 142 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 1350 | 0.030 |
Why?
|
| Apoptosis | 1 | 2019 | 780 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 2015 | 45 | 0.030 |
Why?
|
| Biocatalysis | 1 | 2015 | 22 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2015 | 151 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 482 | 0.030 |
Why?
|
| Models, Biological | 1 | 2015 | 469 | 0.020 |
Why?
|
| Male | 1 | 2019 | 13921 | 0.010 |
Why?
|
| Female | 1 | 2019 | 15624 | 0.010 |
Why?
|